Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1999-2-10
|
pubmed:abstractText |
We report the case of a 15-year-old previously thalassemic girl who, 15 months after allogeneic BMT, developed HBeAg-negative hepatitis B (variant with mu-1896). In the absence of another route of transmission, HBV reactivation is postulated. The time of emergence of the HBV variant (with mu-1896) is probably related to the development of anti-HBe immunity. This mutant strain is associated with fulminant hepatitis. The patient achieved complete remission and HBV eradication despite having moderate GVHD and receiving immunosuppressive therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
919-21
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9827822-Adolescent,
pubmed-meshheading:9827822-Bone Marrow Transplantation,
pubmed-meshheading:9827822-Female,
pubmed-meshheading:9827822-Graft vs Host Disease,
pubmed-meshheading:9827822-Hepatitis B,
pubmed-meshheading:9827822-Hepatitis B e Antigens,
pubmed-meshheading:9827822-Humans,
pubmed-meshheading:9827822-Immunosuppressive Agents,
pubmed-meshheading:9827822-Transplantation, Homologous,
pubmed-meshheading:9827822-beta-Thalassemia
|
pubmed:year |
1998
|
pubmed:articleTitle |
HBeAg-negative hepatitis B in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD.
|
pubmed:affiliation |
First Department of Pediatrics, Aghia Sophia Children's Hospital, University of Athens, Greece.
|
pubmed:publicationType |
Journal Article,
Case Reports
|